chitosan has been researched along with 19-iodocholesterol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azab, AK; Doviner, V; Klein, M; Nissan, A; Orkin, B; Rubinstein, A; Srebnik, M | 1 |
| Azab, AK; Doviner, V; Kleinstern, J; Nissan, A; Orkin, B; Rubinstein, A; Srebnik, M | 2 |
3 other study(ies) available for chitosan and 19-iodocholesterol
| Article | Year |
|---|---|
Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis.
Topics: 19-Iodocholesterol; Animals; Biocompatible Materials; Brachytherapy; Chitosan; Cross-Linking Reagents; Drug Implants; Glutaral; Hydrogels; Iodine Radioisotopes; Rats | 2006 |
Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat.
Topics: 19-Iodocholesterol; Animals; Biocompatible Materials; Biomarkers; Chitosan; Cross-Linking Reagents; Foreign-Body Reaction; Hydrogels; Inflammation; Materials Testing; Organ Specificity; Peritoneum; Prosthesis Implantation; Rats; Skin | 2007 |
Prevention of tumor recurrence and distant metastasis formation in a breast cancer mouse model by biodegradable implant of 131I-norcholesterol.
Topics: 19-Iodocholesterol; Absorbable Implants; Animals; Brachytherapy; Cell Line, Tumor; Chitosan; Cross-Linking Reagents; Female; Glutaral; Half-Life; Hydrogels; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Models, Biological; Neoplasm Metastasis; Oxidation-Reduction; Radiotherapy, Adjuvant; Secondary Prevention; Time Factors; Xenograft Model Antitumor Assays | 2007 |